EDF Health

Selected tag(s): Confidential Business Information (CBI)

EPA’s New Chemicals Program: TSCA dealt EPA a very poor hand

By / Published: April 16, 2009

Richard Denison, Ph.D., is a Senior Scientist.

[The first post in this series can be found here.]

Some in the chemical industry point to EPA’s New Chemicals Program as a robust program, one that could serve as a model for reform of the Toxic Substances Control Act (TSCA).  Most recently, the National Petrochemical & Refiners Association (NPRA) did so in its testimony at a recent House of Representatives subcommittee’s TSCA oversight hearing.  So just how robust is EPA’s program on new chemicals?  Read More »

Posted in Health policy, Regulation / Also tagged , , , | Comments are closed

Tired of Waiting … [with apologies to Ray Davies]

By / Published: August 20, 2008

Richard Denison, Ph.D., is a Senior Scientist.

EDF’s recent news release that gave a less-than-glowing review to the performance of EPA’s Nanoscale Materials Stewardship Program (NMSP) engendered a critique from Michael Heintz of Porter & Wright, accusing us of being “irresponsible” and potentially “sector damaging.” Our release had lamented the mediocre level of participation and lack of transparency surrounding the NMSP. I’ve posted a reply to Michael’s post, but also want to post it here. Read More »

Posted in Health policy, Nanotechnology, Regulation / Tagged | Comments are closed

EPA Nano Authority under TSCA, Part 3: Can EPA Track “Existing” Nanomaterials?

By / Published: June 27, 2008

Richard Denison, Ph.D., is a Senior Scientist.

[Links to posts in this series: Part 1, Part 2, Part 3, Part 4, Part 5]

This was going to be the last post in my series on the fate of nanomaterials under the Toxic Substances Control Act (TSCA), where I turn to what will likely be – at least in the near term – the most common regulatory scenario that will apply:  the extent to which EPA has authority to regulate nanomaterials as “existing” chemicals under TSCA.  But there’s so much to cover that I’ve decided to split this last topic into three separate posts.  Read More »

Posted in Health policy, Nanotechnology, Regulation / Also tagged | Comments are closed